Base de dados : MEDLINE
Pesquisa : I01.409.418.750.600.650.496.485 [Categoria DeCS]
Referências encontradas : 137 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 14 ir para página                         

  1 / 137 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27484319
[Au] Autor:Li MD; Hser YI; Chen Z; Chang L
[Ad] Endereço:State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
[Ti] Título:Promoting Global Health - Prevention and Treatment of Substance Abuse and HIV in Asia.
[So] Source:J Neuroimmune Pharmacol;11(3):379-82, 2016 Sep.
[Is] ISSN:1557-1904
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:This special issue contains 20 papers including 3 Perspectives, 1 Brief Report, 6 Invited Reviews, and 10 Original Articles, which highlight the work by presenters at the second meeting of the biennial Conference Series to Promote Global Health held on April 22-24, 2015 in Hangzhou, Zhejiang, China. These papers focused on the prevalent substance misuse of amphetamine-type-stimulants and opioids, and the increasing prevalence of HIV-infection in Asian countries. The Conference Series is sponsored by the National Institute on Drug Abuse of the U.S. National Institutes of Health, with the goal of exchanging knowledge and ideas related to, and promoting international collaborative work on, the prevention and treatment of substance use disorders and HIV-infection, in order to promote health in Asian and Pacific Islanders and other populations.
[Mh] Termos MeSH primário: Congressos como Assunto/tendências
Saúde Global/tendências
Infecções por HIV/epidemiologia
National Institute on Drug Abuse (U.S.)/tendências
Transtornos Relacionados ao Uso de Substâncias/epidemiologia
[Mh] Termos MeSH secundário: Ásia/epidemiologia
China/epidemiologia
Infecções por HIV/prevenção & controle
Infecções por HIV/terapia
Seres Humanos
Transtornos Relacionados ao Uso de Substâncias/prevenção & controle
Transtornos Relacionados ao Uso de Substâncias/terapia
Resultado do Tratamento
Estados Unidos/epidemiologia
[Pt] Tipo de publicação:INTRODUCTORY JOURNAL ARTICLE
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171018
[Lr] Data última revisão:
171018
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160804
[St] Status:MEDLINE
[do] DOI:10.1007/s11481-016-9695-4


  2 / 137 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27449271
[Au] Autor:Guydish J; Tajima B; Pramod S; Le T; Gubner NR; Campbell B; Roman P
[Ad] Endereço:Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States. Electronic address: joseph.guydish@ucsf.edu.
[Ti] Título:Use of multiple tobacco products in a national sample of persons enrolled in addiction treatment.
[So] Source:Drug Alcohol Depend;166:93-9, 2016 Sep 01.
[Is] ISSN:1879-0046
[Cp] País de publicação:Ireland
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: To explore use of tobacco products in relationship to marketing exposure among persons in addiction treatment. METHOD: A random sample of treatment programs was drawn from the National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN). Participants in each program completed surveys concerning use of tobacco products (N=1113). Exposure to tobacco marketing and counter-marketing, advertising receptivity, and perceived health risks of smoking were tested for their association with use of multiple tobacco products. RESULTS: Prevalence of combustible cigarette use was 77.9%. Weekly or greater use of other products was: e-cigarettes (17.7%), little filtered cigars (8.6%), smokeless tobacco (5.2%), and standard cigars (4.6%) with 24.4% using multiple tobacco products. Compared to single product users, multiple product users smoked more cigarettes per day (OR=1.03, 95% CI 1.01-1.05, p<0.001), were more likely to have tried to quit (OR=1.41, 95% CI 1.02-1.96, p=0.041), reported greater daily exposure to advertising for products other than combustible cigarettes (OR=1.93, CI 1.35-2.75, p<0.001), and greater daily exposure to tobacco counter-marketing (OR=1.70, 95% CI: 1.09-2.63, p=0.019). CONCLUSION: Heavier smokers and those trying to quit may be more likely to use e-cigarettes, little filtered cigars, or smokeless tobacco and have greater susceptibility to their advertising. This highlights the importance of regulating advertising related to smoking cessation as their effectiveness for this purpose has not been demonstrated.
[Mh] Termos MeSH primário: Comportamento Aditivo/epidemiologia
Sistemas Eletrônicos de Liberação de Nicotina/utilização
Centros de Tratamento de Abuso de Substâncias
Tabagismo/epidemiologia
Tabaco sem Fumaça/utilização
[Mh] Termos MeSH secundário: Adulto
Comportamento Aditivo/diagnóstico
Comportamento Aditivo/terapia
Feminino
Seres Humanos
Masculino
Marketing/métodos
Meia-Idade
National Institute on Drug Abuse (U.S.)
Fumar/epidemiologia
Abandono do Hábito de Fumar/métodos
Prevenção do Hábito de Fumar
Centros de Tratamento de Abuso de Substâncias/métodos
Transtornos Relacionados ao Uso de Substâncias/diagnóstico
Transtornos Relacionados ao Uso de Substâncias/epidemiologia
Transtornos Relacionados ao Uso de Substâncias/terapia
Inquéritos e Questionários
Produtos do Tabaco/utilização
Tabagismo/diagnóstico
Tabagismo/prevenção & controle
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171116
[Lr] Data última revisão:
171116
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160725
[St] Status:MEDLINE


  3 / 137 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27257247
[Au] Autor:Stith SS; Vigil JM
[Ad] Endereço:Department of Economics, University of New Mexico, Albuquerque, NM 87131, USA.
[Ti] Título:Federal barriers to Cannabis research.
[So] Source:Science;352(6290):1182, 2016 Jun 03.
[Is] ISSN:1095-9203
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Pesquisa Biomédica/legislação & jurisprudência
Cannabis
Regulamentação Governamental
Aplicação de Novas Drogas em Teste/legislação & jurisprudência
[Mh] Termos MeSH secundário: Cannabis/química
Dronabinol/análise
Governo Federal
Seres Humanos
National Institute on Drug Abuse (U.S.)
Ensaios Clínicos Controlados Aleatórios como Assunto/legislação & jurisprudência
Estados Unidos
[Pt] Tipo de publicação:LETTER
[Nm] Nome de substância:
7J8897W37S (Dronabinol)
[Em] Mês de entrada:1606
[Cu] Atualização por classe:160603
[Lr] Data última revisão:
160603
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160604
[St] Status:MEDLINE
[do] DOI:10.1126/science.aaf7450


  4 / 137 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:26751366
[Au] Autor:Paino M; Aletraris L; Roman P
[Ad] Endereço:Department of Sociology, Anthropology, Social Work and Criminal Justice, Oakland University, Rochester, Michigan.
[Ti] Título:The Relationship Between Client Characteristics and Wraparound Services in Substance Use Disorder Treatment Centers.
[So] Source:J Stud Alcohol Drugs;77(1):160-9, 2016 Jan.
[Is] ISSN:1938-4114
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: The National Institute on Drug Abuse (NIDA) recommends a comprehensive treatment program for individuals with substance use disorder (SUD) in order to treat needs they often have in addition to their SUD. Specifically, NIDA suggests providing services related to the following issues: medical care, mental health care, HIV/AIDS, child care, educational, vocational, family counseling, housing, transportation, financial, and legal. By providing a comprehensive model that combines core and wraparound services, treatment centers can deliver a higher quality of treatment. In this article, we assessed the relationship between client characteristics and the availability of wraparound services in SUD treatment centers. METHOD: We combined two nationally representative samples of treatment centers and used a negative binomial regression and a series of logistic regressions to analyze the relationship between client characteristics and wraparound services. RESULTS: On average, centers offered fewer than half of the wraparound services endorsed by NIDA. Our results indicated that client characteristics were significantly related to the provision of wraparound services. Most notably, the proportion of adolescent clients was positively related to educational services, the proportion of female clients was positively related to child care, but the proportion of clients referred from the criminal justice system was negatively associated with the provision of multiple wraparound services. CONCLUSIONS: Our findings have important implications for SUD clients and suggest that, although centers are somewhat responsive to their clients' ancillary needs, most centers do not offer the majority of wraparound services.
[Mh] Termos MeSH primário: National Institute on Drug Abuse (U.S.)
Centros de Tratamento de Abuso de Substâncias/métodos
Transtornos Relacionados ao Uso de Substâncias/epidemiologia
Transtornos Relacionados ao Uso de Substâncias/terapia
United States Substance Abuse and Mental Health Services Administration
[Mh] Termos MeSH secundário: Adolescente
Adulto
Estudos Transversais
Feminino
Seres Humanos
Masculino
National Institute on Drug Abuse (U.S.)/tendências
Centros de Tratamento de Abuso de Substâncias/tendências
Centros de Tratamento de Abuso de Substâncias/utilização
Transtornos Relacionados ao Uso de Substâncias/diagnóstico
Estados Unidos/epidemiologia
United States Substance Abuse and Mental Health Services Administration/tendências
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, N.I.H., EXTRAMURAL
[Em] Mês de entrada:1608
[Cu] Atualização por classe:170220
[Lr] Data última revisão:
170220
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160112
[St] Status:MEDLINE


  5 / 137 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26862133
[Au] Autor:Morton CM; Hoefinger H; Linn-Walton R; Aikins R; Falkin GP
[Ad] Endereço:Department of Social Work, University of New Hampshire, Durham, NH, USA cory.morton@unh.edu.
[Ti] Título:What Are Youth Asking About Drugs? A Report of NIDA Drug Facts Chat Day.
[So] Source:J Drug Educ;45(3-4):195-210, 2015.
[Is] ISSN:0047-2379
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:The current study analyzes a sample of questions about drugs asked online by youth who participated in the National Institute on Drug Abuse's (NIDA) "Drug Facts Chat Day." The types of drugs youth asked about were coded into 17 substance categories, and the topics they raised were coded into seven thematic categories. The top five queried drugs were marijuana (16.4%), alcohol (8.5%), tobacco (6%), cocaine (5.7), and pharmaceutical drugs (4.5%). The effects of drug use, experience of being high, the addictiveness of drugs, pharmacology, and drug sales were among the more common types of questions to emerge but varied depending on the substance. These findings show the types of information young people are seeking about drugs and have clear implications to inform youth drug education programs.
[Mh] Termos MeSH primário: Comportamento de Busca de Informação
Transtornos Relacionados ao Uso de Substâncias/psicologia
[Mh] Termos MeSH secundário: Adolescente
Feminino
Seres Humanos
Masculino
National Institute on Drug Abuse (U.S.)
Inquéritos e Questionários
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, N.I.H., EXTRAMURAL
[Em] Mês de entrada:1606
[Cu] Atualização por classe:170220
[Lr] Data última revisão:
170220
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160211
[St] Status:MEDLINE
[do] DOI:10.1177/0047237915622084


  6 / 137 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26469642
[Au] Autor:Chandler RK; Kahana SY; Fletcher B; Jones D; Finger MS; Aklin WM; Hamill K; Webb C
[Ad] Endereço:Redonna K. Chandler, Shoshana Y. Kahana, Bennett Fletcher, Dionne Jones, Matthew S. Finger, Will M. Aklin, and Kathleen Hamill are with the National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD. Candace Webb is with Health Resources and Services Administration, HIV/AIDS Burea
[Ti] Título:Data Collection and Harmonization in HIV Research: The Seek, Test, Treat, and Retain Initiative at the National Institute on Drug Abuse.
[So] Source:Am J Public Health;105(12):2416-22, 2015 Dec.
[Is] ISSN:1541-0048
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Large-scale, multisite data sets offer the potential for exploring the public health benefits of biomedical interventions. Data harmonization is an emerging strategy to increase the comparability of research data collected across independent studies, enabling research questions to be addressed beyond the capacity of any individual study. The National Institute on Drug Abuse recently implemented this novel strategy to prospectively collect and harmonize data across 22 independent research studies developing and empirically testing interventions to effectively deliver an HIV continuum of care to diverse drug-abusing populations. We describe this data collection and harmonization effort, collectively known as the Seek, Test, Treat, and Retain Data Collection and Harmonization Initiative, which can serve as a model applicable to other research endeavors.
[Mh] Termos MeSH primário: Pesquisa Biomédica/métodos
Coleta de Dados/métodos
Infecções por HIV/diagnóstico
National Institute on Drug Abuse (U.S.)
[Mh] Termos MeSH secundário: Fármacos Anti-HIV/uso terapêutico
Pesquisa Biomédica/organização & administração
Continuidade da Assistência ao Paciente/organização & administração
Direito Penal
Coleta de Dados/normas
Feminino
Infecções por HIV/tratamento farmacológico
Seres Humanos
Masculino
Modelos Organizacionais
Estudos Multicêntricos como Assunto/métodos
Estudos Prospectivos
Transtornos Relacionados ao Uso de Substâncias/complicações
Estados Unidos
Populações Vulneráveis
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Anti-HIV Agents)
[Em] Mês de entrada:1604
[Cu] Atualização por classe:151107
[Lr] Data última revisão:
151107
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:151016
[St] Status:MEDLINE
[do] DOI:10.2105/AJPH.2015.302788


  7 / 137 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26457926
[Au] Autor:Yeom HS
[Ad] Endereço:a Department of Social Work , James Madison University , Harrisonburg , Virginia , USA.
[Ti] Título:Utilization of Substance Abuse Treatment: Gender Differences among Participants in an Aftercare Program.
[So] Source:Soc Work Public Health;30(7):578-91, 2015.
[Is] ISSN:1937-190X
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:This study examined gender differences in the utilization of substance abuse treatment including inpatient, outpatient, and self-help services, using existing data sets from a National Institute on Drug Abuse study that enrolled 78 females and 141 males in a mixed-gender aftercare program in Massachusetts for a 2-year follow-up period. This study found that women came to the study in greater need of treatment than men. Women utilized significantly more outpatient treatment services than men. The characteristic of female per se led to more utilization of outpatient services, whereas the baseline characteristics of employed status and alcohol use led to less utilization of outpatient services.
[Mh] Termos MeSH primário: Assistência ao Convalescente/utilização
Centros de Tratamento de Abuso de Substâncias/utilização
Transtornos Relacionados ao Uso de Substâncias/terapia
[Mh] Termos MeSH secundário: Adulto
Assistência Ambulatorial/utilização
Bases de Dados Factuais
Feminino
Hospitalização/estatística & dados numéricos
Seres Humanos
Masculino
Massachusetts
National Institute on Drug Abuse (U.S.)
Autocuidado/utilização
Fatores Sexuais
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1612
[Cu] Atualização por classe:161230
[Lr] Data última revisão:
161230
[Sb] Subgrupo de revista:H
[Da] Data de entrada para processamento:151013
[St] Status:MEDLINE
[do] DOI:10.1080/19371918.2015.1084773


  8 / 137 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26359616
[Au] Autor:Hall W; Carter A; Forlini C
[Ad] Endereço:The University of Queensland, Centre for Youth Substance Abuse Research, The University of Queensland, Brisbane, QLD, Australia; Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia; National Addiction Centre, King's College London, London, UK. Electronic address: w.hall@uq.edu.au.
[Ti] Título:The brain disease model of addiction: is it supported by the evidence and has it delivered on its promises?
[So] Source:Lancet Psychiatry;2(1):105-10, 2015 Jan.
[Is] ISSN:2215-0374
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:Since 1997 the US National Institute on Drug Abuse has advocated a brain disease model of addiction (BDMA). We assess the strength of evidence for the BDMA in animals, neuroimaging studies of people with addiction, and current research on the role of genetics in addiction. We critically assess claims about the medical and social benefits of use of the BDMA because the social implications are often implied as a reason to accept this model. Furthermore, we argue that the BDMA is not supported by animal and neuroimaging evidence to the extent its advocates suggest; it has not helped to deliver more effective treatments for addiction; and its effect on public policies toward drugs and people with addiction has been modest. The focus of the BDMA is on disordered neurobiology in a minority of severely addicted individuals, which undermines the implementation of effective and cost-effective policies at the population level to discourage people from smoking tobacco and drinking heavily. The pursuit of high technology direct brain interventions to cure addiction when most individuals with addiction do not have access to effective psychosocial and drug treatments is questionable.
[Mh] Termos MeSH primário: Política de Saúde
Transtornos Relacionados ao Uso de Substâncias/patologia
[Mh] Termos MeSH secundário: Animais
Seres Humanos
National Institute on Drug Abuse (U.S.)
Neuroimagem
Estigma Social
Transtornos Relacionados ao Uso de Substâncias/tratamento farmacológico
Transtornos Relacionados ao Uso de Substâncias/genética
Transtornos Relacionados ao Uso de Substâncias/psicologia
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Em] Mês de entrada:1702
[Cu] Atualização por classe:170206
[Lr] Data última revisão:
170206
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:150912
[St] Status:MEDLINE


  9 / 137 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
PubMed Central Texto completo
Texto completo
[PMID]:25907849
[Au] Autor:Hien DA; Campbell AN; Ruglass LM; Saavedra L; Mathews AG; Kiriakos G; Morgan-Lopez A
[Ad] Endereço:Gordon F. Derner Institute of Advanced Psychological Studies, Adelphi University; Department of Psychiatry, Columbia University College of Physicians and Surgeons, and New York State Psychiatric Institute. Electronic address: dhien@adelphi.edu.
[Ti] Título:Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example.
[So] Source:J Subst Abuse Treat;56:23-33, 2015 Sep.
[Is] ISSN:1873-6483
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Recent federal legislation and a renewed focus on integrative care models underscore the need for economical, effective, and science-based behavioral health care treatment. As such, maximizing the impact and reach of treatment research is of great concern. Behavioral health issues, including the frequent co-occurrence of substance use disorders (SUD) and posttraumatic stress disorder (PTSD), are often complex, with a myriad of factors contributing to the success of interventions. Although treatment guides for comorbid SUD/PTSD exist, most patients continue to suffer symptoms following the prescribed treatment course. Further, the study of efficacious treatments has been hampered by methodological challenges (e.g., overreliance on "superiority" designs (i.e., designs structured to test whether or not one treatment statistically surpasses another in terms of effect sizes) and short term interventions). Secondary analyses of randomized controlled clinical trials offer potential benefits to enhance understanding of findings and increase the personalization of treatment. This paper offers a description of the limits of randomized controlled trials as related to SUD/PTSD populations, highlights the benefits and potential pitfalls of secondary analytic techniques, and uses a case example of one of the largest effectiveness trials of behavioral treatment for co-occurring SUD/PTSD conducted within the National Drug Abuse Treatment Clinical Trials Network (NIDA CTN) and producing 19 publications. The paper concludes with implications of this secondary analytic approach to improve addiction researchers' ability to identify best practices for community-based treatment of these disorders. Innovative methods are needed to maximize the benefits of clinical studies and better support SUD/PTSD treatment options for both specialty and non-specialty healthcare settings. Moving forward, planning for and description of secondary analyses in randomized trials should be given equal consideration and care to the primary outcome analysis.
[Mh] Termos MeSH primário: Terapia Cognitiva/estatística & dados numéricos
Estudos Multicêntricos como Assunto/estatística & dados numéricos
Avaliação de Resultados (Cuidados de Saúde)/estatística & dados numéricos
Ensaios Clínicos Controlados Aleatórios como Assunto/estatística & dados numéricos
Transtornos de Estresse Pós-Traumáticos/terapia
Transtornos Relacionados ao Uso de Substâncias/terapia
[Mh] Termos MeSH secundário: Adulto
Terapia Cognitiva/métodos
Diagnóstico Duplo (Psiquiatria)
Feminino
Seres Humanos
Estudos Multicêntricos como Assunto/normas
National Institute on Drug Abuse (U.S.)
Avaliação de Resultados (Cuidados de Saúde)/normas
Ensaios Clínicos Controlados Aleatórios como Assunto/normas
Estados Unidos
Saúde da Mulher
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, N.I.H., EXTRAMURAL
[Em] Mês de entrada:1605
[Cu] Atualização por classe:170220
[Lr] Data última revisão:
170220
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:150425
[St] Status:MEDLINE


  10 / 137 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:25814055
[Au] Autor:Volkow ND
[Ti] Título:An interview with Nora Volkow.
[So] Source:Trends Pharmacol Sci;36(4):187-8, 2015 Apr.
[Is] ISSN:1873-3735
[Cp] País de publicação:England
[La] Idioma:eng
[Mh] Termos MeSH primário: National Institute on Drug Abuse (U.S.)
Médicos
Transtornos Relacionados ao Uso de Substâncias/terapia
[Mh] Termos MeSH secundário: Feminino
Seres Humanos
National Institute on Drug Abuse (U.S.)/tendências
Médicos/tendências
Transtornos Relacionados ao Uso de Substâncias/diagnóstico
Estados Unidos
[Pt] Tipo de publicação:INTERVIEW
[Em] Mês de entrada:1603
[Cu] Atualização por classe:150406
[Lr] Data última revisão:
150406
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:150328
[St] Status:MEDLINE



página 1 de 14 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde